fda import alert semaglutide green list tirzepatide creates "green list" to block unsafe GLP-1 imports FDA's green list cracks down – September 8, 2025: FDA launches

Retatrutide activates three hormone receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors

Improved Energy and Recovery IV therapy can enhance hydration and nutrient delivery directly to the bloodstream, leading to quicker recovery from fatigue and illness

& Coggeshall, R

A quarter of the loss holding long term once the drug is gone suggests some component of energy expenditure or appetite regulation actually resets, instead of just reverting

They offer real, life-changing benefits for manyyet come with side effects, high costs, and long-term uncertainties